Docking Finds GPCR Ligands in Dark Chemical Matter
- 17 December 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 63 (2) , 613-620
Abstract
High-throughput screening has revealed dark chemical matter, a set of drug-like compounds that has never shown bioactivity despite being extensively assayed. If dark molecules are found active at a therapeutic target, their extraordinary selectivity profiles make excellent starting-points for drug development. We explored if ligands of therapeutically relevant G-protein-coupled receptors could be discovered by structure-based virtual screening of the dark chemical matter. Molecular docking screens against crystal structures of the A2A adenosine and the D4 dopamine receptors were carried out and 53 top-ranked molecules were evaluated experimentally. Two ligands of each receptor were discovered and the most potent had submicromolar affinities. Analysis of bioactivity data showed that the ligands lacked activity at hundreds of off-targets, including several that are associated with adverse effects. Our results demonstrate that virtual screening provides an efficient means to mine the dark chemical space, which could contribute to development of drugs with improved safety profiles.Keywords
Funding Information
- Science for Life Laboratory
- Vetenskapsr?det (2017-4676)
- G?ran Gustafssons Stiftelse f?r Naturvetenskaplig och Medicinsk Forskning
- European Regional Development Fund
- Xunta de Galicia (ED431C 2018/21)
- National Institute of General Medical Sciences (GM71896)
- H2020 European Research Council (715052)
- Swedish strategic research program eSSENCE
This publication has 42 references indexed in Scilit:
- ZINC: A Free Tool to Discover Chemistry for BiologyJournal of Chemical Information and Modeling, 2012
- Ligand discovery from a dopamine D3 receptor homology model and crystal structureNature Chemical Biology, 2011
- Rational Methods for the Selection of Diverse Screening CompoundsACS Chemical Biology, 2011
- Structure-Based Discovery of A2AAdenosine Receptor LigandsJournal of Medicinal Chemistry, 2010
- Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural DatabaseJournal of Chemical Information and Modeling, 2010
- Structure-Based Discovery of Novel Chemotypes for Adenosine A2AReceptor AntagonistsJournal of Medicinal Chemistry, 2010
- Automated Docking Screens: A Feasibility StudyJournal of Medicinal Chemistry, 2009
- Quantifying biogenic bias in screening librariesNature Chemical Biology, 2009
- The influence of drug-like concepts on decision-making in medicinal chemistryNature Reviews Drug Discovery, 2007
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973